| 000 | 00691nam a2200229Ia 4500 | ||
|---|---|---|---|
| 000 | 00947nam a2200241 4500 | ||
| 001 | mosti000011197 | ||
| 003 | MY-WpKST | ||
| 005 | 20210916200807.0 | ||
| 007 | OC | ||
| 008 | 131204s2013####nyuagr#001#0#eng#d | ||
| 020 | _a9781848447172 (alk. paper) | ||
| 039 |
_y201107000000 _zstaff |
||
| 040 | _aMOSTI | ||
| 090 |
_a338.4 _bBRU |
||
| 100 | _aRasmussen, Bruce, | ||
| 245 | 1 | 0 |
_aInnovation and commercialisation in the biopharmaceutical industry: _cBruce Rasmussen |
| 260 |
_aCheltenham, Glos, UK: _bEdward Elgar, _c2010 |
||
| 300 |
_avii, 326 p.: _bill.: _c24 cm |
||
| 504 | _aIncludes bibliographical references (p. 290 - 311) and index | ||
| 942 | _cBK | ||
| 999 |
_c23419 _d23419 |
||